Literature DB >> 26113688

Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure.

Stijn E Verleden1, Dragoş M Vasilescu2, John E McDonough3, David Ruttens4, Robin Vos4, Elly Vandermeulen4, Hannelore Bellon4, Rachel Geenens4, Erik K Verbeken4, Johny Verschakelen4, Dirk E Van Raemdonck4, Wim A Wuyts4, Youri Sokolow5, Christiane Knoop5, Joel D Cooper6, James C Hogg2, Geert M Verleden4, Bart M Vanaudenaerde4.   

Abstract

Chronic lung allograft dysfunction (CLAD) remains the major barrier to long-term success after lung transplantation. This report compares gross and microscopic features of lungs removed from patients receiving a redo-transplant as treatment for CLAD. Lungs donated by patients with either the bronchiolitis obliterans syndrome (BOS) or restrictive allograft syndrome (RAS) phenotype of CLAD and appropriate control lungs (eight per group) were air-inflated, frozen solid and kept frozen while a multi-detector computed tomography (MDCT) was obtained. The lung was then cut into 2-cm thick transverse slices and sampled for micro-CT and histopathology. The MDCT showed reduced lung volume with increased lung weight and density in RAS versus BOS and control (p<0.05). Although pre-terminal bronchioles were obstructed in both phenotypes, RAS lungs showed a reduction of pre-terminal bronchioles (p<0.01). Micro-CT and matched histopathology showed that RAS was associated with reduced numbers of terminal bronchioles/lung compared to BOS and controls (p<0.01), with expansion of the interstitial compartment and obliteration of the alveolar airspaces by fibrous connective tissue. RAS is associated with greater destruction of both pre-terminal and terminal bronchioles. Additionally, the interstitial compartments are expanded and alveolar airspaces are obliterated by accumulation of fibrous connective tissue.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26113688     DOI: 10.1183/09031936.00010615

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

1.  [Lung transplantation : Histomorphological diagnosis and clinical aspects].

Authors:  J Wohlschlaeger; F Laenger; J Gottlieb; T Hager; A Seidel; D Jonigk
Journal:  Pathologe       Date:  2019-05       Impact factor: 1.011

Review 2.  [Fibrotic remodeling of the lung following lung and stem-cell transplantation].

Authors:  Christopher Werlein; Max Ackermann; Thia Leandra Hoffmann; Florian Laenger; Danny Jonigk
Journal:  Pathologe       Date:  2021-01-08       Impact factor: 1.011

3.  Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.

Authors:  Michael P Combs; Meng Xia; David S Wheeler; Elizabeth A Belloli; Natalie M Walker; Russell R Braeuer; Dennis M Lyu; Susan Murray; Vibha N Lama
Journal:  J Heart Lung Transplant       Date:  2020-04-19       Impact factor: 10.247

Review 4.  Chronic lung allograft dysfunction phenotypes and treatment.

Authors:  Stijn E Verleden; Robin Vos; Bart M Vanaudenaerde; Geert M Verleden
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

5.  The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.

Authors:  Jan H von der Thüsen; Elly Vandermeulen; Robin Vos; Birgit Weynand; Erik K Verbeken; Stijn E Verleden
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

6.  Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients.

Authors:  Elizabeth A Belloli; Irina Degtiar; Xin Wang; Gregory A Yanik; Linda J Stuckey; Stijn E Verleden; Ella A Kazerooni; Brian D Ross; Susan Murray; Craig J Galbán; Vibha N Lama
Journal:  Am J Respir Crit Care Med       Date:  2017-04-01       Impact factor: 21.405

7.  Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

Authors:  Stijn E Verleden; Naoya Tanabe; John E McDonough; Dragoş M Vasilescu; Feng Xu; Wim A Wuyts; Davide Piloni; Laurens De Sadeleer; Stijn Willems; Cindy Mai; Jeroen Hostens; Joel D Cooper; Erik K Verbeken; Johny Verschakelen; Craig J Galban; Dirk E Van Raemdonck; Thomas V Colby; Marc Decramer; Geert M Verleden; Naftali Kaminski; Tillie-Louise Hackett; Bart M Vanaudenaerde; James C Hogg
Journal:  Lancet Respir Med       Date:  2020-02-13       Impact factor: 30.700

8.  Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.

Authors:  S E Verleden; R Vos; E Vandermeulen; D Ruttens; H Bellon; T Heigl; D E Van Raemdonck; G M Verleden; V Lama; B D Ross; C J Galbán; B M Vanaudenaerde
Journal:  Am J Transplant       Date:  2016-07-29       Impact factor: 8.086

Review 9.  Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD).

Authors:  Anne-Laure Brun; Marie-Laure Chabi; Clément Picard; François Mellot; Philippe A Grenier
Journal:  Diagnostics (Basel)       Date:  2021-04-30

10.  Chronic lung allograft pathology lesions in two rat strain combinations.

Authors:  Federica Pezzuto; Francesca Lunardi; Marta Vadori; Davide Zampieri; Federica Casiraghi; Nadia Azzollini; Stefania Edith Vuljan; Marco Mammana; Luca Vedovelli; Marco Schiavon; Dario Gregori; Emanuele Cozzi; Federico Rea; Fiorella Calabrese
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.